Medindia

X

Regeneron Says FDA Halts Pain Killer Drug Development

by Kathy Jones on  December 28, 2010 at 9:07 PM Drug News   - G J E 4
In a major blow for Regeneron Pharmaceuticals, the US Food and Drug Administration (FDA) has put an end to the development of its new pain killer drug after a similar study by another company resulted in a serious nerve problem in a volunteer.
 Regeneron Says FDA Halts Pain Killer Drug Development
Regeneron Says FDA Halts Pain Killer Drug Development
Advertisement

The experimental drug, REGN475/SAR164877, is being developed by Regeneron along with Sanofi-Aventis SA but was asked to halt the research after a similar study by Pfizer which led to the development of avascular necrosis in the patient.

Advertisement
Pfizer is currently developing a similar NGF-inhibitor but a number of patients who took part in the study had to undergo joint replacement surgeries due avascular necrosis.

The FDA then contacted both the companies, requesting it to suspend their trials until a clear picture emerged.


Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All